ATE525360T1 - Neuartige imidazolinylmethyl-aryl-sulfonamide - Google Patents
Neuartige imidazolinylmethyl-aryl-sulfonamideInfo
- Publication number
- ATE525360T1 ATE525360T1 AT09709428T AT09709428T ATE525360T1 AT E525360 T1 ATE525360 T1 AT E525360T1 AT 09709428 T AT09709428 T AT 09709428T AT 09709428 T AT09709428 T AT 09709428T AT E525360 T1 ATE525360 T1 AT E525360T1
- Authority
- AT
- Austria
- Prior art keywords
- novel
- methyl aryl
- aryl sulfonamides
- imidazolinyl
- imidazolinyl methyl
- Prior art date
Links
- -1 IMIDAZOLINYL METHYL Chemical class 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000004031 partial agonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2584108P | 2008-02-04 | 2008-02-04 | |
| PCT/EP2009/050841 WO2009098136A1 (en) | 2008-02-04 | 2009-01-26 | Novel imidazolinylmethyl aryl sulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE525360T1 true ATE525360T1 (de) | 2011-10-15 |
Family
ID=40679581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09709428T ATE525360T1 (de) | 2008-02-04 | 2009-01-26 | Neuartige imidazolinylmethyl-aryl-sulfonamide |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20090197934A1 (de) |
| EP (1) | EP2238116B1 (de) |
| JP (1) | JP2011511026A (de) |
| KR (1) | KR20100096262A (de) |
| CN (1) | CN101925581A (de) |
| AT (1) | ATE525360T1 (de) |
| AU (1) | AU2009211506A1 (de) |
| BR (1) | BRPI0906632A2 (de) |
| CA (1) | CA2711728A1 (de) |
| IL (1) | IL206611A0 (de) |
| MX (1) | MX2010007929A (de) |
| WO (1) | WO2009098136A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220401415A1 (en) | 2019-10-25 | 2022-12-22 | Curasen Therapeutics, Inc. | Methods for treating neurological disorders with alpha1a-ar partial agonists |
| CN115884964A (zh) * | 2020-08-27 | 2023-03-31 | 库拉森疗法公司 | α1A-肾上腺素能受体激动剂和使用方法 |
| CN112624975A (zh) * | 2020-11-27 | 2021-04-09 | 华南农业大学 | 一种妥拉唑林半抗原、人工抗原、抗体及其制备和应用 |
| CN117229291B (zh) * | 2023-11-10 | 2024-03-15 | 山东大学 | 内体-溶酶体转运靶向嵌合体降解剂及其制备方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| BR0309668A (pt) * | 2002-04-23 | 2005-03-01 | Hoffmann La Roche | Imidazolinilmetil aralquilsulfonamidas |
| BRPI0906982A2 (pt) * | 2008-02-04 | 2015-07-21 | Hoffmann La Roche | N-[3-bromo-2-cloro-4-(4,5-di-hidro-ih-imidazol-2-ilmetil )-fenil]-metanossulfonamida como agonista parcial adrenégico alfa-1 a para o tratamento de incontinência |
| CA2711726A1 (en) * | 2008-02-04 | 2009-08-13 | F. Hoffmann-La Roche Ag | Novel imidazolinylmethyl aryl sulfonamides |
-
2009
- 2009-01-26 AT AT09709428T patent/ATE525360T1/de not_active IP Right Cessation
- 2009-01-26 MX MX2010007929A patent/MX2010007929A/es not_active Application Discontinuation
- 2009-01-26 WO PCT/EP2009/050841 patent/WO2009098136A1/en not_active Ceased
- 2009-01-26 AU AU2009211506A patent/AU2009211506A1/en not_active Abandoned
- 2009-01-26 BR BRPI0906632-2A patent/BRPI0906632A2/pt not_active IP Right Cessation
- 2009-01-26 CA CA2711728A patent/CA2711728A1/en not_active Abandoned
- 2009-01-26 KR KR1020107016642A patent/KR20100096262A/ko not_active Ceased
- 2009-01-26 JP JP2010545430A patent/JP2011511026A/ja active Pending
- 2009-01-26 CN CN2009801029606A patent/CN101925581A/zh active Pending
- 2009-01-26 EP EP09709428A patent/EP2238116B1/de not_active Not-in-force
- 2009-02-04 US US12/365,282 patent/US20090197934A1/en not_active Abandoned
-
2010
- 2010-06-24 IL IL206611A patent/IL206611A0/en unknown
-
2011
- 2011-06-03 US US13/152,611 patent/US20110230535A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010007929A (es) | 2010-08-09 |
| CN101925581A (zh) | 2010-12-22 |
| CA2711728A1 (en) | 2009-07-13 |
| US20090197934A1 (en) | 2009-08-06 |
| KR20100096262A (ko) | 2010-09-01 |
| IL206611A0 (en) | 2010-12-30 |
| JP2011511026A (ja) | 2011-04-07 |
| EP2238116B1 (de) | 2011-09-21 |
| AU2009211506A1 (en) | 2009-08-13 |
| EP2238116A1 (de) | 2010-10-13 |
| WO2009098136A1 (en) | 2009-08-13 |
| US20110230535A1 (en) | 2011-09-22 |
| BRPI0906632A2 (pt) | 2015-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
| EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
| EA201001724A1 (ru) | Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| ATE517882T1 (de) | Chinolinderivate | |
| EA201071329A1 (ru) | Диамидные производные адамантана и их применение | |
| EA201170922A1 (ru) | Производные сульфонамида | |
| EA201491607A1 (ru) | Модуляторы толлподобных рецепторов | |
| EA201071288A1 (ru) | Тризамещенные пиразолы в качестве модуляторов рецепторов ацетилхолина | |
| MX390264B (es) | Antagonistas d2, metodos de sintesis y metodos de uso. | |
| GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
| UA112317C2 (uk) | Похідні 2-(1,2,3-триазол-2-іл)бензаміду та 3-(1,2,3-триазол-2-іл)піколінаміду як антагоністи рецептора орексину | |
| EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
| EA201390163A1 (ru) | Гетеробициклические производные в качетстве ингибиторов hcv | |
| EA201290394A1 (ru) | Морфолинотиазолы в качестве позитивных аллостерических модуляторов альфа 7 | |
| EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
| EA201190017A1 (ru) | Аминоэфирные производные алкалоидов и их медицинские композиции | |
| EA200970341A1 (ru) | Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов | |
| EA201300436A8 (ru) | Совместные кристаллы и соли ингибиторов ccr3 | |
| DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
| EA200970065A1 (ru) | Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38 | |
| EA201001747A1 (ru) | Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств | |
| EA201270428A1 (ru) | Замещенные n-фенил-1-(4-пиридинил)-1н-пиразол-3-амины | |
| EA201170722A1 (ru) | Лактамы в качестве ингибиторов бета-секретазы | |
| EA201290534A1 (ru) | Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |